Internet Computer ICP

Bitcoin Cash BCH

Litecoin LTC

ETFMG Treatments, Testing and Advancements ETF

GERM

Current price

17.98 USD +0.22 USD (+1.24%)

Company –

Category Health

Exchange NYSE ARCA

Capitalization 12 524 080 USD

Yield for 12 month -23.00 %

Week

Month

Year

GERM

21.11.2021 - 28.11.2021

ETFMG Treatments, Testing and Advancements ETF, a constituent of the ETF, is listed on the NYSE ARCA. Its market capitalization stands at 12 524 080 USD. Over the past year, it has generated a yield of -23.00 %. The fund's net expense ratio, a critical measure of operational efficiency, is recorded at 0.68 %. A significant allocation in cash assets underscores its liquidity position and risk management strategy. Turning to technical indicators, they offer a granular perspective on the fund's market behavior, historical trends, and potential forward momentum. For an in-depth analysis get premium access.

Analytics

Total Assets

12 524 080 USD

Net Expense Ratio

0.68 %

Annual Holdings Turnover

30 %

Long 0.83%

Short -

Net Assets 0.83%

Long 75.62%

Short -

Net Assets 75.62%

Long 23.55%

Short -

Net Assets 23.55%

Long -

Short -

Net Assets -

Long -

Short -

Net Assets -

1y Volatility 19.29%

Returns YTD -19.45%

3y Volatility 29.44%

Returns 1Y -24.15%

3y ExpReturn 0.00%

Returns 3Y -17.34%

3y SharpRatio -0.63%

Returns 5Y 0.00%

Returns 10Y 0.00%

Dividend growth over 5 years

–

Continuous growth

1 year

3 years

5 years

10 years

21.11.2021 - 28.11.2021

15.67 USD 24.83 USD

50 Day MA 17.04 USD

200 Day MA 19.62 USD

ETFMG Treatments, Testing and Advancements ETF